Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Schizophrenia and Schizoaffective Disorders Clinical Trials

A listing of Schizophrenia and Schizoaffective Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (193) clinical trials

This is an adaptive, Phase II/III study in 2 parts (i.e. Part 1 (dose ranging) and Part 2 (Hypothesis testing)). NaBen® is granted Breakthrough Therapy Designation by US FDA as treatment for refractory schizophrenia.

Phase N/A

This study will evaluate the efficacy of adjunctive pimavanserin in the treatment of schizophrenia. The study is randomized and double-blind, meaning both the participant and the tester are unaware which group is receiving the experimental and placebo treatments. This is an active-control trial, so those in the placebo group will ...

Phase N/A

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ADJUNCTIVE PIMAVANSERIN FOR THE TREATMENT OF SCHIZOPHRENIA

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophre

Phase

INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, FIXED-DOSE STUDY OF Lu AF35700 IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA

Phase

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase